ASX - By Stock
|
LRS |
Re:
Ann: Appointment of Peter Oliver to Executive Director
|
|
hubbabubba
|
19 |
11K |
24 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
19
|
11K
|
24
|
|
ASX - By Stock
|
AZS |
Re:
Ann: 209m High-Grade Lithium Intersection at Andover
|
|
hubbabubba
|
222 |
84K |
15 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
222
|
84K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
hubbabubba
|
1.3K |
540K |
4 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
540K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
hubbabubba
|
1.3K |
540K |
15 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
540K
|
15
|
|
Charts
|
LRS |
Re:
LRS General Discussion
|
|
hubbabubba
|
17K |
6.8M |
24 |
20/07/23 |
20/07/23 |
Charts
|
17K
|
6.8M
|
24
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
hubbabubba
|
3.4K |
1.1M |
43 |
15/07/23 |
15/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
43
|
|
ASX - By Stock
|
LRS |
Re:
Ann: New Salinas lithium corridor confirmed
|
|
hubbabubba
|
214 |
93K |
12 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
214
|
93K
|
12
|
|
ASX - By Stock
|
LRS |
Re:
Ann: New Salinas lithium corridor confirmed
|
|
hubbabubba
|
214 |
93K |
22 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
214
|
93K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD
|
|
hubbabubba
|
914 |
284K |
1 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
914
|
284K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD
|
|
hubbabubba
|
914 |
284K |
6 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
914
|
284K
|
6
|
|
Charts
|
LRS |
Re:
LRS General Discussion
|
|
hubbabubba
|
17K |
6.8M |
18 |
20/12/22 |
20/12/22 |
Charts
|
17K
|
6.8M
|
18
|
|
ASX - By Stock
|
RNU |
Re:
Ann: Trading Halt
|
|
hubbabubba
|
349 |
182K |
25 |
25/11/22 |
25/11/22 |
ASX - By Stock
|
349
|
182K
|
25
|
|
ASX - By Stock
|
MSB |
Re:
MSB Holders Only
|
|
hubbabubba
|
518 |
145K |
5 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
518
|
145K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Guess the reason for MSB Trading Halt
|
|
hubbabubba
|
317 |
155K |
4 |
17/12/20 |
17/12/20 |
ASX - By Stock
|
317
|
155K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ethics Approval to Treat COVID-19 Patients in Australia
|
|
hubbabubba
|
320 |
128K |
4 |
03/09/20 |
03/09/20 |
ASX - By Stock
|
320
|
128K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Overwhelming efficacy - the stats required
|
|
hubbabubba
|
576 |
230K |
1 |
25/08/20 |
25/08/20 |
ASX - By Stock
|
576
|
230K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
hubbabubba
|
17K |
6.5M |
1 |
20/08/20 |
20/08/20 |
ASX - By Stock
|
17K
|
6.5M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO action tonight
|
|
hubbabubba
|
3.1K |
1.4M |
2 |
15/08/20 |
15/08/20 |
ASX - By Stock
|
3.1K
|
1.4M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: ODAC Votes in Favor of Remestemcel-L for GvHD
|
|
hubbabubba
|
142 |
65K |
2 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
142
|
65K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
8-2 VICTORY! Now what do we open at?
|
|
hubbabubba
|
67 |
29K |
25 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
67
|
29K
|
25
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
hubbabubba
|
2.0K |
681K |
8 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
681K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
hubbabubba
|
2.0K |
681K |
4 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
681K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
hubbabubba
|
2.0K |
681K |
6 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
681K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
hubbabubba
|
2.0K |
681K |
5 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
681K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
hubbabubba
|
2.0K |
681K |
11 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
681K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
hubbabubba
|
2.0K |
681K |
17 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
681K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
hubbabubba
|
2.0K |
681K |
2 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
681K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
hubbabubba
|
2.0K |
681K |
4 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
2.0K
|
681K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
hubbabubba
|
2.0K |
681K |
5 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
2.0K
|
681K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
hubbabubba
|
2.0K |
681K |
3 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
2.0K
|
681K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
hubbabubba
|
17K |
6.5M |
19 |
07/08/20 |
07/08/20 |
ASX - By Stock
|
17K
|
6.5M
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
|
|
hubbabubba
|
854 |
425K |
14 |
06/08/20 |
06/08/20 |
ASX - By Stock
|
854
|
425K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
MESO action tonight
|
|
hubbabubba
|
3.1K |
1.4M |
39 |
05/08/20 |
05/08/20 |
ASX - By Stock
|
3.1K
|
1.4M
|
39
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
hubbabubba
|
17K |
6.5M |
133 |
03/08/20 |
03/08/20 |
ASX - By Stock
|
17K
|
6.5M
|
133
|
|
ASX - By Stock
|
MSB |
Re:
Dr. Michael Bowdish - Reflections on MSB's NIH Trial
|
|
hubbabubba
|
185 |
59K |
13 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
185
|
59K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
hubbabubba
|
17K |
6.5M |
11 |
19/06/20 |
19/06/20 |
ASX - By Stock
|
17K
|
6.5M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
hubbabubba
|
17K |
6.5M |
22 |
01/06/20 |
01/06/20 |
ASX - By Stock
|
17K
|
6.5M
|
22
|
|
ASX - By Stock
|
MSB |
Re:
The competition to Remestemcel-L in COVID-19
|
|
hubbabubba
|
159 |
59K |
9 |
16/05/20 |
16/05/20 |
ASX - By Stock
|
159
|
59K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Tomorrow’s Shareprice
|
|
hubbabubba
|
77 |
44K |
1 |
13/05/20 |
13/05/20 |
ASX - By Stock
|
77
|
44K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Tomorrow’s Shareprice
|
|
hubbabubba
|
77 |
44K |
12 |
13/05/20 |
13/05/20 |
ASX - By Stock
|
77
|
44K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Googala's 2020 Share Price Competitions
|
|
hubbabubba
|
303 |
102K |
1 |
08/05/20 |
08/05/20 |
ASX - By Stock
|
303
|
102K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
clinicaltrials.gov - MSCs in COVID-19 ARDS
|
|
hubbabubba
|
199 |
92K |
30 |
05/05/20 |
05/05/20 |
ASX - By Stock
|
199
|
92K
|
30
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast(?) Australian Covid-19 Trial Victor Chang Cardiac Research Institute
|
|
hubbabubba
|
86 |
44K |
38 |
03/05/20 |
03/05/20 |
ASX - By Stock
|
86
|
44K
|
38
|
|
ASX - By Stock
|
MSB |
Re:
Gilead vs Mesoblast
|
|
hubbabubba
|
274 |
109K |
8 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
274
|
109K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Holders please read
|
|
hubbabubba
|
104 |
45K |
5 |
28/04/20 |
28/04/20 |
ASX - By Stock
|
104
|
45K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L
|
|
hubbabubba
|
847 |
331K |
11 |
25/04/20 |
25/04/20 |
ASX - By Stock
|
847
|
331K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L
|
|
hubbabubba
|
847 |
331K |
8 |
25/04/20 |
25/04/20 |
ASX - By Stock
|
847
|
331K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L
|
|
hubbabubba
|
847 |
331K |
44 |
25/04/20 |
25/04/20 |
ASX - By Stock
|
847
|
331K
|
44
|
|
ASX - By Stock
|
MSB |
Re:
Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L
|
|
hubbabubba
|
847 |
331K |
4 |
24/04/20 |
24/04/20 |
ASX - By Stock
|
847
|
331K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L
|
|
hubbabubba
|
847 |
331K |
7 |
24/04/20 |
24/04/20 |
ASX - By Stock
|
847
|
331K
|
7
|
|